ROSEN, NATIONAL TRIAL LAWYERS, Encourages Humacyte, Inc. Investors to Secure Counsel Before Important Deadline in ...
NEW YORK, Dec. 26, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Humacyte, Inc. (NASDAQ: HUMA) between May 10, 2024 and October 17, 2024, both dates inclusive (the “Class Period”), of …